369 related articles for article (PubMed ID: 32145929)
1. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
Cobo A; Giles J; Paolelli S; Pellicer A; Remohí J; García-Velasco JA
Fertil Steril; 2020 Apr; 113(4):836-844. PubMed ID: 32145929
[TBL] [Abstract][Full Text] [Related]
2. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
3. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
4. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
5. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
[TBL] [Abstract][Full Text] [Related]
6. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
7. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
8. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
[TBL] [Abstract][Full Text] [Related]
9. Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate.
Cobo A; Garrido N; Pellicer A; Remohí J
Fertil Steril; 2015 Dec; 104(6):1426-34.e1-8. PubMed ID: 26353081
[TBL] [Abstract][Full Text] [Related]
10. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis.
Cobo A; Coello A; de Los Santos MJ; Giles J; Pellicer A; Remohí J; García-Velasco JA
Reprod Biomed Online; 2021 Apr; 42(4):725-732. PubMed ID: 33573907
[TBL] [Abstract][Full Text] [Related]
11. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
Khiat S; Provansal M; Bottin P; Saias-Magnan J; Metzler-Guillemain C; Courbiere B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():65-70. PubMed ID: 32784054
[TBL] [Abstract][Full Text] [Related]
13. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
14. Fertility preservation for women with ovarian endometriosis: results from a retrospective cohort study.
Elizur SE; Aizer A; Yonish M; Shavit T; Orvieto R; Mashiach R; Cohen SB; Berkowitz E
Reprod Biomed Online; 2023 Feb; 46(2):332-337. PubMed ID: 36564221
[TBL] [Abstract][Full Text] [Related]
15. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons.
Cobo A; García-Velasco JA; Remohí J; Pellicer A
Fertil Steril; 2021 May; 115(5):1091-1101. PubMed ID: 33933172
[TBL] [Abstract][Full Text] [Related]
16. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
17. Fertility preservation for patients affected by endometriosis should ideally be carried out before surgery.
Santulli P; Bourdon M; Koutchinsky S; Maignien C; Marcellin L; Maitrot-Mantelet L; Pocate Cheriet K; Patrat C; Chapron C
Reprod Biomed Online; 2021 Nov; 43(5):853-863. PubMed ID: 34649771
[TBL] [Abstract][Full Text] [Related]
18. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
[TBL] [Abstract][Full Text] [Related]
19. Prospective controlled study to evaluate laboratory and clinical outcomes of oocyte vitrification obtained in in vitro fertilization patients aged 30 to 39 years.
Chang CC; Elliott TA; Wright G; Shapiro DB; Toledo AA; Nagy ZP
Fertil Steril; 2013 Jun; 99(7):1891-7. PubMed ID: 23481277
[TBL] [Abstract][Full Text] [Related]
20. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
